ruxolitinib,bms-986158,fedratinib
incyte,novartis,bms
['rux,(-crux),(-trux),(-deruxtecan)', 'ruxolitinib', '#myelof', 'bms-986158', 'rux,(-crux),(-trux)', 'fedra', 'bms']
what a fantastic interview w/ dr haifa kathrin al-ali, of ! we discussed data from a phase 1/2 study of bms-986158 alone and in combination w/ ruxolitinib or fedratinib in intermediate- or high-risk #myelofibrosis. #eha2023 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.